COVID-19: Sinopharm starts phase three trial in Peru
CGTN
01:34

The Chinese pharmaceutical giant Sinopharm has started the third phase of a COVID-19 vaccine trial in Peru. It comes as the number of coronavirus deaths in the country has topped 30,000.

Check out The China Report, our new weekly newsletter. Subscribe here!